Cabrera-Jardines R, Acatitla-Acevedo GA, Rojas-Castañeda E, Moreno-Hernández M, Navarrete-Cisneros MG, Ponce de León-Garduño A, Sifuentes-Osornio J, Rodríguez-Weber FL

Language: Spanish
References: 24
Page: 674-685
PDF size: 250.65 Kb.

ABSTRACT

Background: Hospital-acquired infections represent a constant public health problem due to their relationship with increment in mortality, health-care costs, labor disability and length of stay hospital.
Objectivo: To determine the most relevant epidemiological indicators, risk factors, mortality, microbiology and antibiotic-resistance patterns in patients with hospitalacquired pneumonia at Hospital Angeles Pedregal, Mexico City, between January 1, 2016 and February 28, 2019.
Materials and Methods: A retrospective, epidemiology study, using data from Nosocomial-Infections-Control Office from January 1st, 2016 to February 28th, 2019 at Hospital Angeles Pedregal, Mexico City. Patients were included by using IDSA definitions of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia and Mexican National Norm for Nosocomial Infections.
Results: Seventy-two cases of both hospital-acquired pneumonia and ventilatorassociated pneumonia were obtained. Rate of global incidence was 1.8 cases per 1000 patients and a cumulative incidence of 42.1 cases per 1000 patients. The most common pathogens were gram-negative rods. P. aeruginosa and S. maltophilia were the most prevalent. In the case of P. aeruginosa it was obtained resistance to ceftriaxone, ceftazidime, cefepime, ciprofloxacin, imipenem and meropenem.
Conclusions: It is important to recognize the risk factors most associated with the appearance of hospital-acquired pneumonia, seeking to prevent new cases.

REFERENCES

1. Cardo D, Dennehy PH, Halverson P, Fishman N, et al. Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol 2010 31 (11): 1101-5. doi: 10.1086/656912.

2. Garita-Alonso RM, Zambrano-Tobón BG. Prevalencia y microbiología de la neumonía nosocomial en el servicio de medicina interna. Med Int Mex 2016; 32 (5): 542-550.

3. Centro Estatal de Vigilancia Epidemiológica y Control de Enfermedades. México: Secretaría de Salud, 2014.

4. Cabrera RA, Laguna HG, Villa-Gómez OA, Méndez RR, Guzmán GR. Neumonía adquirida en hospitales. Un problema común que merece mayor atención. Med Int Mex 2009; 25 (1): 31-37.

5. Díaz E, Martín-Loeches I, Vallés J. Neumonía nosocomial. Enferm Infecc Microbiol Clin 2013; 31 (10): 692-698. DOI: 10.1016/j.eimc.2013.04.014

6. Shorr A, Zilderberg M, Micek S, Kollef M. Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respir Med 2017; 122: 76-80. doi: 10.1016/j.rmed.2016.11.023.

7. Kalil, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63 (5): e61-e111. doi: 10.1093/cid/ciw353.

8. Mandel L, Niederman M. Aspiration pneumonia. N Engl J Med 2019; 380: 651-63.

9. DGE (2016). Manual de Procedimientos Estandarizados para la Vigilancia Epidemiológica Hospitalaria. CD MX, México. SS. http://187.191.75.115/gobmx/salud/documentos/ manuales/28_Manual_RHoVE.pdf.

10. Metlay P, Waterer G, Long A, Anzueto A, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200: e45-e67. doi: 10.1164/rccm.201908-1581ST.

11. Norma Oficial Mexicana NOM-045-SSA2-2005, Para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales.

12. Russell CD, Koch O, Laurenson IF, O’Shea DT, et al. Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study. J Hospital Infect 2016; 92: 273-279. doi: 10.1016/j.jhin.2015.11.013.

13. Giuliano KK, Baker D, Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control 2018; 46: 322-7. doi: 10.1016/j. ajic.2017.09.005.

14. Medición de la prevalencia de infecciones nosocomiales en hospitales generales de las principales instituciones públicas de salud. Secretaría de Salud, México, 2011.

15. Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ. Antibacterial resistance leadership group, A primer on ampC β-lactamases: Necessary knowledge for an increasingly multidrug-resistant world. Clin Infect Dis 2019; 69 (8): 1446-1455.

16. Garita-Alonso RM, Zambrano-Tobón BG. Prevalencia y microbiología de neumonía nosocomial en el servicio de Medicina Interna. Med Int Méx 2016; 32 (5): 542-550.

17. Sosa-Hernández O, Matías-Téllez B, Estrada-Hernández A, Cureño-Díaz MA, et al. Incidence and cost of ventilatorassociated pneumonia in the adult intensive care unit of a tertiary referral hospital in Mexico. Am J Infect Control 2019; 47: e21-e25. doi: 10.1016/j.ajic.2019.02.031.

18. Rosenthal VD and INICC members. Effectiveness of a multidimensional approach for prevention of ventilatorassociated pneumonia in adult intensive care units from 14 developing countries of four continents. Critical Care Medicine 2012; 40 (12): 3121-3128. doi: 10.1097/ CCM.0b013e3182657916.

19. Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol 2020; 41 (1): 1-18. doi: 10.1017/ice.2019.296.

20. Ángeles-Garay U, Velázquez-Chávez Y, Anaya-Flores VE, Valencia-Martínez JC, et al. Infecciones nosocomiales en un hospital de alta especialidad. Factores asociados a mortalidad. Rev Med Inst Mex Seguro Soc 2005; 43 (5): 381-391.

21. Rosenthal VD, Bart-Erdene I, Gupta D, Belkebir S, Rajhans P, et al. International Nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control. 2019; 48 (4): 423-432. doi: 10.1016/j.ajic.2019.08.023.

22. Rincón-León H, Navarro-Fuentes K. Tendencias de resistencia antimicrobiana en patógenos aislados de infecciones nosocomiales. Rev Med Inst Mex Seguro Soc. 2016; 54 (1): 32-41.

23. Lara Hernández B, Vásquez Fuentes P, Mix Vidal A, Aguilera Fuenzalida P, Saldías-Peñafiel P. Neumonías asociadas a los cuidados de salud y nuevas guías clínicas. Toma de decisiones desde urgencias. Revista Chilena de Medicina intensiva 2018; 33 (1): 41-47.

24. Burillo A, Muñoz P, Bouza E. Risk stratification for multidrug- resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis 2019; 32 (6): 626-37. doi: 10.1097/ QCO.0000000000000599.